We are live on ! Find out more
VAR

Varian Medical Systems, Inc.
VAR

Delisted

VAR was delisted on the 14th of April, 2021.

597 hedge funds and large institutions have $11.7B invested in Varian Medical Systems, Inc. in 2019 Q4 according to their latest regulatory filings, with 92 funds opening new positions, 172 increasing their positions, 210 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more funds holding in top 10

Funds holding in top 10: 15 (+4)

134% more call options, than puts

Call options by funds: $34.7M | Put options by funds: $14.8M

124% more first-time investments, than exits

New positions opened: 92 | Existing positions closed: 41

19% more capital invested

Capital invested by funds: $9.81B → $11.7B (+$1.91B)

6% more funds holding

Funds holding: 562597 (+35)

18% less repeat investments, than reductions

Existing positions increased: 172 | Existing positions reduced: 210

Holders
597
Holders Change
+35
Holders Change %
+6.23%
% of All Funds
11.76%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.1%
New
92
Increased
172
Reduced
210
Closed
41
Calls
$34.7M
Puts
$14.8M
Net Calls
+$19.9M
Net Calls Change
+$4.03M
Name Holding Trade Value Shares
Change
Change in
Stake
JG
376
Jefferies Group
New York
$551K +$495K +3,878 New
WCM
377
Washington Capital Management
Washington
$540K
VanEck Associates
378
VanEck Associates
New York
$527K +$474K +3,712 New
CA
379
Commerzbank Aktiengesellschaft
Germany
$513K -$114K -890 -20%
NMIMC
380
Northwestern Mutual Investment Management Company
Wisconsin
$502K +$8.29K +65 +2%
MYIA
381
Mount Yale Investment Advisors
Colorado
$488K +$443K +3,473 New
Jane Street
382
Jane Street
New York
$484K -$483K -3,782 -53%
BFS
383
Bradley Foster & Sargent
Connecticut
$484K +$1.4K +11 +0.3%
BLAM
384
Bourne Lent Asset Management
New York
$482K
William Blair & Company
385
William Blair & Company
Illinois
$467K -$121K -947 -22%
QT
386
Quantbot Technologies
New York
$466K -$923K -7,231 -69%
CAN
387
Cetera Advisor Networks
California
$466K +$17.7K +139 +4%
CLOS
388
Compagnie Lombard Odier SCmA
Switzerland
$437K
RJT
389
Raymond James Trust
Florida
$434K -$81.5K -639 -17%
BIAS
390
Beacon Investment Advisory Services
New Jersey
$432K -$17.9K -140 -4%
NA
391
NewEdge Advisors
Louisiana
$431K +$59.7K +468 +18%
CNBT
392
Canandaigua National Bank & Trust
New York
$424K +$381K +2,987 New
CAG
393
Crestwood Advisors Group
Massachusetts
$411K
Kovitz Investment Group Partners
394
Kovitz Investment Group Partners
Illinois
$405K +$1.53K +12 +0.4%
FA
395
FDx Advisors
Illinois
$404K -$171K -1,341 -32%
BNP Paribas Asset Management
396
BNP Paribas Asset Management
France
$403K +$80.9K +634 +29%
AssetMark Inc
397
AssetMark Inc
California
$386K +$333K +2,608 +2,308%
NIM
398
Northeast Investment Management
Massachusetts
$373K
WAM
399
Wealthspire Advisors (Maryland)
Maryland
$373K +$13.1K +103 +4%
NSAM
400
North Star Asset Management
Wisconsin
$369K

VAR Hedge Fund Activity: Q4 2019 in Review

597 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Varian Medical Systems, Inc. (VAR) for Q4 2019, worth a combined $11.7B — up 19% from $9.81B a quarter earlier.

Buyers outnumbered sellers: 92 funds opened new VAR positions and 41 closed out — a net gain of 51 holders — while 172 added to existing stakes and 210 trimmed.

The largest buyer was Marshall Wace North America, adding an estimated $91.4M. The largest seller was Loomis, Sayles & Company, cutting an estimated $164M.

  • 597 institutional investors held Varian Medical Systems, Inc. (VAR) as of Q4 2019, up from 562 in Q3 2019.
  • Funds reported $11.7B of Varian Medical Systems, Inc. stock for Q4 2019, up 19% quarter-over-quarter.
  • 92 funds opened new Varian Medical Systems, Inc. positions in Q4 2019 and 41 closed out, a net change of +51 holders.
  • The largest Varian Medical Systems, Inc. buyer in Q4 2019 was Marshall Wace North America, an estimated $91.4M added.
  • The largest Varian Medical Systems, Inc. seller in Q4 2019 was Loomis, Sayles & Company, an estimated $164M sold.

Based on aggregated 13F filings for Q4 2019.